IPOs, Initial Public Offerings: pre & post IPO

+31% Acceleron Pharma (XLRN

Print this entry

SIGN UP  here  to make better investment decisions, join our very active user community.

+31% Acceleron Pharma (XLRN)   quote  Priced at $15 range top

For new Stifel Nicolas analyst reports including FISH, ESPR, FLEX, SALE, EPAM, BFAM, COTY, ECOM, PF, RH, GTS, VOYA:  email your contact info,  name, mailing address (for compliance purposes) to Randy Hunt,  Senior Vice President/Investments, huntr@stifel.com


Leave a Reply

 

Login

Lost your password?